You are here

  • Home
  • Archive
  • Volume 76, Issue 11
  • Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus

 

Online download statistics by month:

Online download statistics by month: July 2017 to August 2023

AbstractFullPdf
Jul 201725392585663
Aug 2017934979225
Sep 2017232232100
Oct 2017610615263
Nov 2017404408196
Dec 201718918958
Jan 201820020061
Feb 201839537851
Mar 201826025428
Apr 201821921945
May 201811812042
Jun 201811111122
Jul 201810910739
Aug 2018908224
Sep 2018919135
Oct 2018939446
Nov 2018606044
Dec 2018505035
Jan 2019555529
Feb 2019716635
Mar 2019616126
Apr 2019474528
May 2019858537
Jun 2019616129
Jul 2019868627
Aug 2019646048
Sep 2019706741
Oct 2019737236
Nov 2019747039
Dec 2019534718
Jan 2020363320
Feb 2020565240
Mar 2020363625
Apr 2020333229
May 2020585633
Jun 2020443828
Jul 2020464438
Aug 2020382731
Sep 2020423926
Oct 2020726429
Nov 2020453946
Dec 2020605439
Jan 2021463822
Feb 2021504330
Mar 2021564930
Apr 2021625567
May 2021443734
Jun 2021635332
Jul 2021524941
Aug 20216964132
Sep 2021706545
Oct 2021787653
Nov 2021655634
Dec 2021817049
Jan 202211210527
Feb 202227126622
Mar 2022888829
Apr 2022949534
May 2022899146
Jun 2022918636
Jul 2022827731
Aug 2022828342
Sep 2022747328
Oct 2022918646
Nov 20221009628
Dec 2022837825
Jan 2023716621
Feb 202312611837
Mar 2023878224
Apr 2023524640
May 2023888135
Jun 2023908442
Jul 2023676333
Aug 2023686943
Total10712105513992